| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3909233 | The Breast | 2011 | 5 Pages |
Abstract
⺠Invasive lobular breast cancer (ILC) is less responsive to neoadjuvant chemotherapy than ductal cancer (IDC). ⺠Patients with ILC also seem to benefit less from adjuvant chemotherapy than patients with IDC. ⺠Further research, based on randomized data or larger patient series, is urgently needed.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Wilfred Truin, Adri C. Voogd, Gerard Vreugdenhil, Maurice J.C. van der Sangen, Mike W.P.M. van Beek, Rudi M.H. Roumen,